Register today and help find a cure.
What they mean and why they're important
See where the next discovery will come from
Get inspired and learn about how you can help today.
3 September 2014 FDA grants orphan drug status to Promedior's PRM-151 for myelofibrosis
1 September 2014 September is Blood Cancer Awareness Month
5 August 2014 FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis
Get news alerts